Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels
- PMID:22699906
- PMCID: PMC3394933
- DOI: 10.1523/JNEUROSCI.0305-12.2012
Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels
Abstract
We examined whether the effect of the apolipoprotein E (APOE) genotype on functional brain connectivity is modulated by gender in healthy older human adults. Our results confirm significantly decreased connectivity in the default mode network in healthy older APOE ε4 carriers compared with ε3 homozygotes. More important, further testing revealed a significant interaction between APOE genotype and gender in the precuneus, a major default mode hub. Female ε4 carriers showed significantly reduced default mode connectivity compared with either female ε3 homozygotes or male ε4 carriers, whereas male ε4 carriers differed minimally from male ε3 homozygotes. An additional analysis in an independent sample of healthy elderly using an independent marker of Alzheimer's disease, i.e., spinal fluid levels of tau, provided corresponding evidence for this gender-by-APOE interaction. Together, these results converge with previous work showing a higher prevalence of the ε4 allele among women with Alzheimer's disease and, critically, demonstrate that this interaction between APOE genotype and gender is detectable in the preclinical period.
Figures





Similar articles
- Intrinsic functional connectivity alterations in cognitively intact elderly APOE ε4 carriers measured by eigenvector centrality mapping are related to cognition and CSF biomarkers: a preliminary study.Luo X, Qiu T, Jia Y, Huang P, Xu X, Yu X, Shen Z, Jiaerken Y, Guan X, Zhou J, Zhang M; ADNI.Luo X, et al.Brain Imaging Behav. 2017 Oct;11(5):1290-1301. doi: 10.1007/s11682-016-9600-z.Brain Imaging Behav. 2017.PMID:27714554
- Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.Wang X, et al.J Alzheimers Dis. 2015;45(3):781-95. doi: 10.3233/JAD-142556.J Alzheimers Dis. 2015.PMID:25624419
- Interactive effects of the APOE and BDNF polymorphisms on functional brain connectivity: the Tasmanian Healthy Brain Project.Pietzuch M, Bindoff A, Jamadar S, Vickers JC.Pietzuch M, et al.Sci Rep. 2021 Jul 15;11(1):14514. doi: 10.1038/s41598-021-93610-0.Sci Rep. 2021.PMID:34267235Free PMC article.
- Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW.Wishart HA, et al.Am J Psychiatry. 2006 Sep;163(9):1603-10. doi: 10.1176/ajp.2006.163.9.1603.Am J Psychiatry. 2006.PMID:16946187
- Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.Sunderland T, et al.Biol Psychiatry. 2004 Nov 1;56(9):670-6. doi: 10.1016/j.biopsych.2004.07.021.Biol Psychiatry. 2004.PMID:15522251
Cited by
- Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.Johnson CE, Duncan MJ, Murphy MP.Johnson CE, et al.J Alzheimers Dis. 2024;97(1):31-74. doi: 10.3233/JAD-230527.J Alzheimers Dis. 2024.PMID:38007653Free PMC article.Review.
- Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022.Kong F, Wu T, Dai J, Cai J, Zhai Z, Zhu Z, Xu Y, Sun T.Kong F, et al.PLoS One. 2024 Jan 19;19(1):e0295008. doi: 10.1371/journal.pone.0295008. eCollection 2024.PLoS One. 2024.PMID:38241287Free PMC article.
- Serotonin Receptor Gene Polymorphisms Are Associated with Cerebrospinal Fluid, Genetic, and Neuropsychological Biomarkers of Alzheimer's Disease.Babić Leko M, Nikolac Perković M, Španić E, Švob Štrac D, Pleić N, Vogrinc Ž, Gunjača I, Bežovan D, Nedić Erjavec G, Klepac N, Borovečki F, Zemunik T, Pivac N, Hof PR, Šimić G.Babić Leko M, et al.Biomedicines. 2022 Dec 2;10(12):3118. doi: 10.3390/biomedicines10123118.Biomedicines. 2022.PMID:36551873Free PMC article.
- ApoE4: an emerging therapeutic target for Alzheimer's disease.Safieh M, Korczyn AD, Michaelson DM.Safieh M, et al.BMC Med. 2019 Mar 20;17(1):64. doi: 10.1186/s12916-019-1299-4.BMC Med. 2019.PMID:30890171Free PMC article.Review.
- Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, Maruff P, Donohue MC, Rentz DM, Kirn D, Hedden T, Chhatwal J, Schultz AP, Johnson KA, Villemagne VL, Sperling RA; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging, Biomarker and Lifestyle study of ageing; Harvard Aging Brain Study.Buckley RF, et al.Alzheimers Dement. 2018 Sep;14(9):1193-1203. doi: 10.1016/j.jalz.2018.04.010. Epub 2018 May 24.Alzheimers Dement. 2018.PMID:29803541Free PMC article.
References
- Allen EA, Erhardt EB, Damaraju E, Gruner W, Segall JM, Silva RF, Havlicek M, Rachakonda S, Fries J, Kalyanam R, Michael AM, Caprihan A, Turner JA, Eichele T, Adelsheim S, Bryan AD, Bustillo J, Clark VP, Feldstein Ewing SW, Filbey F, et al. A baseline for the multivariate comparison of resting state networks. Front Syst Neurosci. 2011;5:2. - PMC - PubMed
- Ashburner J, Friston KJ. Voxel-based morphometry–the methods. Neuroimage. 2000;11:805–821. - PubMed
- Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, Smith SM, Beckmann CF, Adelstein JS, Buckner RL, Colcombe S, Dogonowski AM, Ernst M, Fair D, Hampson M, Hoptman MJ, Hyde JS, Kiviniemi VJ, Kötter R, Li SJ, Lin CP, et al. Toward discovery science of human brain function. Proc Natl Acad Sci U S A. 2010;107:4734–4739. - PMC - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
- UL1 TR000117/TR/NCATS NIH HHS/United States
- P01 AG019724/AG/NIA NIH HHS/United States
- R01 AG032306/AG/NIA NIH HHS/United States
- R01 AG032289/AG/NIA NIH HHS/United States
- AG032306/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- UL1 TR001998/TR/NCATS NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- U19 AG010483/AG/NIA NIH HHS/United States
- R01 NS073498/NS/NINDS NIH HHS/United States
- CAPMC/ CIHR/Canada
- P30 AG013846/AG/NIA NIH HHS/United States
- NS073498/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous